Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 1,2,4-Benzenetriol, 5-(2-aminoethyl)-, hydrobromide (1:1)

1,2,4-Benzenetriol, 5-(2-aminoethyl)-, hydrobromide (1:1)

pharmaceutical raw materials
1,2,4-Benzenetriol, 5-(2-aminoethyl)-, hydrobromide (1:1) structure

1,2,4-Benzenetriol, 5-(2-aminoethyl)-, hydrobromide (1:1) 

structure
  • CAS No:

    636-00-0

  • Formula:

    C8H11NO3.BrH

  • Chemical Name:

    1,2,4-Benzenetriol, 5-(2-aminoethyl)-, hydrobromide (1:1)

  • Synonyms:

    1,2,4-Benzenetriol,5-(2-aminoethyl)-,hydrobromide (1:1);1,2,4-Benzenetriol,5-(2-aminoethyl)-,hydrobromide;6-Hydroxydopamine hydrobromide;6-Hydroxydopamine hydrogen bromide;2-(2,4,5-Trihydroxyphenyl)ethylamine hydrobromide

  • Categories:

    Biochemical Engineering  >  Amino Acids and Derivatives

Description

Oxidopamine hydrobromide is a selective catecholaminergic neurotoxin, depletes brain catecholamine levels via uptake and accumulation by a transport mechanism specific to these neurons. In vitro: Oxidopamine hydrobromide-induced apoptosis of PC12 cells was initiated by superoxide generation followed by caspase cascade activation, which was associated with the suppressed Akt phosphorylation and increased p38 phosphorylation. It is likely that pCPT-cAMP prevented the Oxidopamine hydrobromi


A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.

1,2,4-Benzenetriol, 5-(2-aminoethyl)-, hydrobromide (1:1) Basic Attributes

250.09

249.000046

211-247-0

TWC1D4W0WB

238469

DTXSID30212972

2922299090

Characteristics

86.71000

1.96300

tan to brown solid

216-220 °C(lit.)

406ºC at 760 mmHg

199.3ºC

2-8°C

Safety Information

NONH for all modes of transport

3

36/37/38

26-36

DC4600000

Xi

P261-P305 + P351 + P338

H315-H319-H335

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)|Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)

6 Hydroxydopamine

1,2,4-Benzenetriol, 5-(2-aminoethyl)-, hydrobromide (1:1) Use and Manufacturing

Biochemical reagents can induce Parkinson~"s disease rat model.

Computed Properties

Molecular Weight:250.09
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:2
Exact Mass:249.00006
Monoisotopic Mass:249.00006
Topological Polar Surface Area:86.7
Heavy Atom Count:13
Complexity:142
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Recommended Suppliers of 1,2,4-Benzenetriol, 5-(2-aminoethyl)-, hydrobromide (1:1)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.